NCT05574894View on ClinicalTrials.gov

Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

PHASE3CompletedINTERVENTIONAL

Enrollment

692

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions

Growth HormoneAdvanced Maternal AgePGT-A

Interventions

DRUG

Growth hormone

Growth hormone is supplemented during the ovarian stimulation till the day of trigger

DRUG

GnRH antagonist

GnRH antagonist protocol for ovarian stimulation

Trial Locations (1)

200011

Shanghai JIAI Genetics and IVF Institute, Shanghai

All Listed Sponsors

lead

ShangHai Ji Ai Genetics & IVF Institute

OTHER

NCT05574894 - Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study | Biotech Hunter | Biotech Hunter